Cargando…
Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes
BACKGROUND: Seasonal Allergic Rhinitis is characterised by inflammation of the nasal mucosa upon exposure to common aeroallergens, affecting up to 20–25 % of the population. For those patients whose symptoms are not controlled by standard medical treatment, allergen specific immunotherapy is a thera...
Autores principales: | Steveling, Esther Helen, Lao-Araya, Mongkol, Koulias, Christopher, Scadding, Guy, Eifan, Aarif, James, Louisa K., Dumitru, Alina, Penagos, Martin, Calderón, Moisés, Andersen, Peter Sejer, Shamji, Mohamed, Durham, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682243/ https://www.ncbi.nlm.nih.gov/pubmed/26682038 http://dx.doi.org/10.1186/s13601-015-0087-2 |
Ejemplares similares
-
Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
por: Scadding, G. W., et al.
Publicado: (2015) -
Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
por: Penagos, Martin, et al.
Publicado: (2018) -
Grass pollen nasal challenge is associated with increases in Th2 cytokines, Eotaxin, MDC and IL-6 in nasal fluid
por: Scadding, Guy, et al.
Publicado: (2013) -
Local and systemic effects of cat allergen nasal provocation
por: Scadding, G. W., et al.
Publicado: (2015) -
Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
por: Boonpiyathad, Tadech, et al.
Publicado: (2021)